I went with my father for his office visit (new patient-not diabetic) and asked the Doctor at the end of the visit if he has prescribed any Afreeza with his response - 2 patients that are very happy with the results. When I go back in 3 weeks I will ask if they were samples or scrips and how they liked the Sanofi's rep presentation and I will ask about lung testing. This doctor has a general practice and is a Endo
Vice President Scientific Research
Obesity is a rapidly becoming a global epidemic and underlies many disease conditions including diabetes and cardiovascular disease. Current treatment options are limited and are challenged by undesirable side effects. Oxyntomodulin (OXY) is an endogenous peptide hormone that signals satiety in healthy individuals. High circulating OXY concentrations are associated with satiety and low OXY concentrations are associated with a feeling of hunger. This activity profile positions OXY as a potential treatment for obesity. To address this unmet medical need, this presentation will introduce an approach to developing an orally inhaled dry powder OXY product administered using a small, breath-powered inhaler for obesity therapy.
The audience will learn about oxyntomodulin, a potential new obesity therapy and about the administration of peptides by oral inhalation using a simple, patient-friendly approach.